Preclinical evaluation for engraftment of CD34


Journal

Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 28 05 2020
revised: 27 07 2020
accepted: 19 03 2021
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 6 5 2021
Statut: epublish

Résumé

Sickle cell disease (SCD) is caused by a 20A > T mutation in the β-globin gene. Genome-editing technologies have the potential to correct the SCD mutation in hematopoietic stem cells (HSCs), producing adult hemoglobin while simultaneously eliminating sickle hemoglobin. Here, we developed high-efficiency viral vector-free non-footprint gene correction in SCD CD34

Identifiants

pubmed: 33948577
doi: 10.1016/j.xcrm.2021.100247
pii: S2666-3791(21)00063-X
pmc: PMC8080237
doi:

Substances chimiques

Antigens, CD34 0
Hemoglobin, Sickle 0
RNA, Guide 0
beta-Globins 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100247

Déclaration de conflit d'intérêts

L.L., C.A., and M.V.P. were employees at MaxCyte during the period of this work.

Références

Bone Marrow Transplant. 2001 Jun;27(11):1201-9
pubmed: 11551032
Nat Biotechnol. 2018 Jan;36(1):95-102
pubmed: 29176614
Mol Ther Methods Clin Dev. 2018 Mar 22;9:247-256
pubmed: 29766032
Gene Ther. 2014 Feb;21(2):148-57
pubmed: 24257347
JAMA. 2014 Jul 2;312(1):48-56
pubmed: 25058217
Stem Cells. 2017 Mar;35(3):586-596
pubmed: 27739611
Sci Transl Med. 2019 Jul 31;11(503):
pubmed: 31366580
Blood. 1995 Jun 1;85(11):3048-57
pubmed: 7538814
Mol Ther. 2019 Sep 4;27(9):1586-1596
pubmed: 31253582
Mol Ther. 2012 Oct;20(10):1882-92
pubmed: 22871664
Blood. 1984 Apr;63(4):921-6
pubmed: 6200161
Nat Rev Genet. 2014 May;15(5):321-34
pubmed: 24690881
Mol Ther Methods Clin Dev. 2021 Mar 03;21:121-132
pubmed: 33816645
Mol Ther Methods Clin Dev. 2019 Jan 25;13:187-196
pubmed: 30788387
Mol Ther Nucleic Acids. 2019 Sep 6;17:277-288
pubmed: 31279229
Biochem Biophys Res Commun. 1973 Aug 21;53(4):1240-5
pubmed: 4748816
Hum Gene Ther. 1999 Aug 10;10(12):1953-64
pubmed: 10466629
Nat Rev Immunol. 2007 Feb;7(2):118-30
pubmed: 17259968
J Virol. 2009 Oct;83(19):9854-62
pubmed: 19625395
Mol Ther Nucleic Acids. 2013 Sep 17;2:e122
pubmed: 24045711
Science. 2013 Oct 11;342(6155):253-7
pubmed: 24115442
Nucleic Acids Res. 2019 Sep 5;47(15):7955-7972
pubmed: 31147717
Sci Transl Med. 2017 Jan 11;9(372):
pubmed: 28077679
N Engl J Med. 1999 Apr 1;340(13):1021-30
pubmed: 10099145
Nature. 2016 Nov 17;539(7629):384-389
pubmed: 27820943
N Engl J Med. 2011 Sep 1;365(9):807-14
pubmed: 21879898
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15018-15027
pubmed: 32527859
Gene Ther. 2011 Nov;18(11):1078-86
pubmed: 21544097
Nat Commun. 2019 Oct 2;10(1):4479
pubmed: 31578323
Cell Rep. 2020 Sep 1;32(9):108093
pubmed: 32877675
N Engl J Med. 2017 Mar 2;376(9):848-855
pubmed: 28249145
Blood. 2011 Jan 20;117(3):798-807
pubmed: 21041718
N Engl J Med. 2018 Jul 19;379(3):226-235
pubmed: 30021096
Blood. 1996 Dec 15;88(12):4701-10
pubmed: 8977264
Sci Transl Med. 2016 Oct 12;8(360):360ra134
pubmed: 27733558
PLoS One. 2017 Jan 6;12(1):e0169774
pubmed: 28060945
Blood. 2017 Oct 26;130(17):1946-1948
pubmed: 28887325
Mol Ther Methods Clin Dev. 2016 Sep 14;3:16059
pubmed: 27652288
Blood. 2013 Apr 18;121(16):3216-27
pubmed: 23327923
Haematologica. 2020 Feb 13;105(10):e497
pubmed: 33054091
Sci Rep. 2018 Jul 19;8(1):10950
pubmed: 30026539
Cell Transplant. 2010;19(11):1465-73
pubmed: 21214970
Mol Ther. 2018 Feb 7;26(2):468-479
pubmed: 29221806
N Engl J Med. 2009 Dec 10;361(24):2309-17
pubmed: 20007560
Cell Stem Cell. 2019 May 2;24(5):821-828.e5
pubmed: 31051134
Nat Commun. 2019 Jun 28;10(1):2866
pubmed: 31253785
Hum Gene Ther Clin Dev. 2017 Sep;28(3):136-144
pubmed: 28447889
Blood. 1998 Aug 15;92(4):1131-41
pubmed: 9694700
Mol Ther. 2019 Aug 7;27(8):1389-1406
pubmed: 31178391
N Engl J Med. 2017 Feb 2;376(5):429-439
pubmed: 27959701
Nat Biotechnol. 2019 Mar;37(3):224-226
pubmed: 30809026
Nat Cell Biol. 2016 Dec 23;19(1):1-9
pubmed: 28008184
Stem Cells Transl Med. 2020 May;9(5):590-602
pubmed: 32034898
Nat Rev Mol Cell Biol. 2018 Jan;19(1):20-30
pubmed: 29018283
Mol Ther Methods Clin Dev. 2019 Nov 11;15:430-437
pubmed: 31890735
Nat Med. 2016 Sep;22(9):987-90
pubmed: 27525524
Exp Hematol. 2011 Jul;39(7):795-805
pubmed: 21549175
Blood. 2015 Apr 23;125(17):2597-604
pubmed: 25733580

Auteurs

Naoya Uchida (N)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.
Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.

Linhong Li (L)

MaxCyte, Gaithersburg, MD, USA.

Tina Nassehi (T)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Claire M Drysdale (CM)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Morgan Yapundich (M)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Jackson Gamer (J)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Juan J Haro-Mora (JJ)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Selami Demirci (S)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Alexis Leonard (A)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Aylin C Bonifacino (AC)

Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA.

Allen E Krouse (AE)

Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA.

N Seth Linde (NS)

Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA.

Cornell Allen (C)

MaxCyte, Gaithersburg, MD, USA.

Madhusudan V Peshwa (MV)

MaxCyte, Gaithersburg, MD, USA.

Suk See De Ravin (SS)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.

Robert E Donahue (RE)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Harry L Malech (HL)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.

John F Tisdale (JF)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH